Because PharmaHemp’s first business is that of a supplier of raw materials, many of the micro brands you may have come across in Europe and beyond maybe white-labelling PharmaHemp’s CBD oil; in other words, they put their own stamp (branding and packaging) on PharmaHemp’s formulas or requested bespoke formulas. Why not just take it directly from the source? We like dealing with the main supplier directly, particularly in the case of PharmaHemp, who already has a very strong brand identity and ethos. We match their prices and import their products regularly to have the freshest batches of their stock available. Visit the PharmaHemp collection.
While this is true to an extent, the simple fact of the matter remains that pure CBD oil with customer-backed qualities is a rarity in the legal hemp marketplace. The vast majority of CBD oil online (even products that are extracted with CO2 technology and "verified" with third-party lab reports), is still subpar in terms of potency, purity, and effectiveness.
There are a number of possible side effects to using CBD oil, such as fatigue, dry mouth, lightheadedness, hypotension, and impaired motor functions. However, when used in moderate amounts, most people do not experience these side effects, and none of them are known for being fatal or particularly dangerous. More than 20,000 studies have been done in the past 15 years on cannabis, hemp, and cannabinoids, and the results have been overwhelmingly supportive of the therapeutic potential and viability of CBD oil. That being said, some people should be cautious before using this powerful oil.
Another major reason why CBD oil has been positively received in some parts of the medical community is its apparent effect on cancer and tumor growth.A study done by the researchers of the Institute of Toxicology and Pharmacology, University of Rostock, Germany recommends the use of CBD oil (even direct injection into tumors) to eliminate or reduce the size of the tumors. The antioxidants in CBD hemp oil also provide anti-mutagenic properties and lower users’ risk of cancer.
In fact, the U.S. Food and Drug Administration (FDA) approved Epidiolex (a drug made with a purified form of CBD oil) in June 2018 for the treatment of seizures associated with two rare and severe forms of epilepsy in patients 2 years of age and older. These two epilepsy forms are known as Lennox-Gastaut syndrome and Dravet syndrome. Epidiolex is the first FDA-approved drug that contains a purified drug substance derived from marijuana.